BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 170936)

  • 21. Effect of exercise training on adenyl cyclase and phosphodiesterase in skeletal muscle, heart, and liver.
    Dohm GL; Pennington SN; Barakat H
    Biochem Med; 1976 Oct; 16(2):138-42. PubMed ID: 187178
    [No Abstract]   [Full Text] [Related]  

  • 22. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 23. The activation of brain adenylate cyclase and brain cyclic-nucleotide phosphodiesterase by seven calmodulin derivatives.
    Thiry P; Vandermeers A; Vandermeers-Piret MC; Rathe J; Christophe J
    Eur J Biochem; 1980 Jan; 103(2):409-14. PubMed ID: 6244945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related parallel decline in beta-adrenergic receptors, adenylate cyclase and phosphodiesterase activity in rat erythrocyte membranes.
    Bylund DB; Tellez-Iñon MT; Hollenberg MD
    Life Sci; 1977 Aug; 21(3):403-10. PubMed ID: 197363
    [No Abstract]   [Full Text] [Related]  

  • 25. Adenylate cyclase and phosphodiesterase in transitional epithelium of the urinary bladder.
    Chlapowski FJ
    Life Sci; 1976 Feb; 18(3):351-9. PubMed ID: 176554
    [No Abstract]   [Full Text] [Related]  

  • 26. Interactions of antiepileptic drugs on adenylate cyclase and phosphodiesterases in rat and mouse cerebrum.
    Palmer GC
    Exp Neurol; 1979 Feb; 63(2):322-35. PubMed ID: 220075
    [No Abstract]   [Full Text] [Related]  

  • 27. Interactions of gangliosides with adenylate cyclase and cyclic AMP phosphodiesterase in rat brain homogenates and synaptosomes [proceedings].
    Lovely JR; Butt NM; Saeed SA
    Biochem Soc Trans; 1980 Feb; 8(1):128-9. PubMed ID: 6245952
    [No Abstract]   [Full Text] [Related]  

  • 28. Calcium and papaverine interaction with soluble cardiac phosphodiesterase.
    Carpenedo F; Gaion RM; Fassina G
    Biochem Pharmacol; 1975 Nov; 24(22):2069-73. PubMed ID: 174573
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation between adenosine 3',5'-cyclic monosphosphate levels, adenylate cyclase activity, and adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in tissue culture cells stimulated by serum.
    Matsumoto T; Uchida T
    J Biochem; 1975 Oct; 78(4):811-5. PubMed ID: 175046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic nucleotide phosphodiesterases of rabbit renal cortex. Characterization of brush border membrane activities.
    Filburn CR; Sacktor B
    Arch Biochem Biophys; 1976 May; 174(1):249-61. PubMed ID: 7201
    [No Abstract]   [Full Text] [Related]  

  • 31. The relationship between the growth characteristics of somatic cell hybrids and their level of camp and activities of adenylate cyclase and camp phosphodiesterase.
    Tisdale MJ; Phillips BJ
    Exp Cell Res; 1976 Apr; 99(1):63-71. PubMed ID: 177303
    [No Abstract]   [Full Text] [Related]  

  • 32. Modulator binding protein. Bovine brain protein exhibiting the Ca2+-dependent association with the protein modulator of cyclic nucleotide phosphodiesterase.
    Wang JH; Desai R
    J Biol Chem; 1977 Jun; 252(12):4175-84. PubMed ID: 193860
    [No Abstract]   [Full Text] [Related]  

  • 33. Thyroid hormone control of cyclic nucleotide phosphodiesterases and the regulation of the sensitivity of the liver to hormones.
    Gumaa KA; Hothersall JS; Greenbaum AL; McLean P
    FEBS Lett; 1977 Aug; 80(1):45-8. PubMed ID: 196928
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of dopamine receptor sensitivity by an endogenous protein activator or adenylate cyclase.
    Costa E; Gnegy MG; Uzunov P
    Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S47-8. PubMed ID: 193053
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of a calcium-binding protein as a calcium-dependent regulator of brain adenylate cyclase.
    Brostrom CO; Huang YC; Breckenridge BM; Wolff DJ
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):64-8. PubMed ID: 164029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-sensitive phosphodiesterase. Its localization, hormonal stimulation, and oxidative stabilization.
    Kono T; Robinson FW; Sarver JA
    J Biol Chem; 1975 Oct; 250(19):7826-35. PubMed ID: 170271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of partially purified NSILA on adenylate cyclase, phosphodiesterase and 3',5'-cyclic AMP in fat cells.
    Hepp KD; Renner R; Langley J; Häring HU
    Mol Cell Endocrinol; 1975 Oct; 3(4):309-21. PubMed ID: 172393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The distribution of the Ca++-dependent protein activator of cyclic nucleotide phosphodiesterase in invertebrates.
    Waisman D; Stevens FC; Wang JH
    Biochem Biophys Res Commun; 1975 Aug; 65(3):975-82. PubMed ID: 168896
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclic 3':5'-nucleotide phosphodiesterase. Stimulation of bovine brain cytoplasmic enzyme by lysophosphatidylcholine.
    Pichard AL; Cheung WY
    J Biol Chem; 1977 Jul; 252(14):4872-5. PubMed ID: 194898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural similarities between the Ca2+-dependent regulatory proteins of 3':5'-cyclic nucleotide phosphodiesterase and actomyosin ATPase.
    Watterson DM; Harrelson WG; Keller PM; Sharief F; Vanaman TC
    J Biol Chem; 1976 Aug; 251(15):4501-13. PubMed ID: 181375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.